Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

MORU’s Mo Yin and MOCRU’s Myo Maung Maung Swe were awarded a prize by the NDM’s Graduate Studies Committee. Very competitive awards, the prizes are given annually to current or recently graduated students of NDM supervisors on the basis of their publication record, the impact and novelty of their research, references, and research within their department.

Mo Yin and Myo Maung Maung Swe

A DPhil Student in Ben Cooper’s Bacterial Resistance Analysis Group (BRAG) in MAEMOD, Mo Yin won the Year 3 Prize. In his nomination submission, Ben noted Mo Yin many achievements, her outstanding publication record and important contributions to COVID-19 response.

MOCRU MD/Researcher Dr Myo Maung Maung Swe was awarded the Public Engagement Prize, for his public theatre performance, Fever and Antibiotic Use, a Wellcome Public Engagement grant-funded MOCRU forum theatre project aiming to change antibiotic and medicine usage habits in local Yangon communities.

Similar stories

Ensitrelvir shows strong antiviral activity against COVID-19 in first head-to-head comparison with Paxlovid

The oral antiviral ensitrelvir is a highly effective treatment for COVID-19, showing potent in-vivo antiviral activity comparable to ritonavir-boosted nirmatrelvir (Paxlovid), say MORU, Mahidol and University of Oxford researchers in a major international study published in The Lancet Infectious Diseases.